Ret heterozygous mice have enhanced intestinal adaptation after massive small bowel resection

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 302, Issue 10, 2012, Pages

  Hitch, Meredith C ^a   Leinicke, Jennifer A ^b   Wakeman, Derek ^b   Guo, Jun ^b   Erwin, Chris R ^b   Rowland, Kathryn J ^b   Merrick, Ellen C ^a   Heuckeroth, Robert O ^a,c   Warner, Brad W ^b  

^a Division of Pediatric Gastroenterology   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Enteric nervous system; Epidermal growth factor receptor; Short bowel syndrome

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCAGON LIKE PEPTIDE 2; MESSENGER RNA; PROTEIN C FOS;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; INTESTINAL ADAPTATION; INTESTINE CELL; INTESTINE FUNCTION; INTESTINE INNERVATION; MORBIDITY; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SMALL INTESTINE RESECTION; WILD TYPE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; APOPTOSIS; CELL PROLIFERATION; ENTERIC NERVOUS SYSTEM; GLUCAGON-LIKE PEPTIDE 2; GLYCOPROTEINS; HETEROZYGOTE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINE, LARGE; INTESTINE, SMALL; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR, EPIDERMAL GROWTH FACTOR; SHORT BOWEL SYNDROME;

EID: 84861147753     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00296.2011     Document Type: Article

References (46)

1. Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, Borrego S, Pelet A, Arnold S, Miao X, Griseri P, Brooks AS, Antinolo G, de Pontual L, Clement-Ziza M, Munnich A, Kashuk C, West K, Wong KK, Lyonnet S, Chakravarti A, Tam PK, Ceccherini I, Hofstra RM, Fernandez R. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45: 1-14, 2008.
2. Arighi E, Borrello MG, Sariola H. RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev 16: 441-467, 2005.
3. Bahrami J, Yusta B, Drucker DJ. ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel. Gastroenterology 138: 2447-2456, 2010.
4. Barnard JA, Graves-Deal R, Pittelkow MR, DuBois R, Cook P, Ramsey GW, Bishop PR, Damstrup L, Coffey RJ. Auto-and crossinduction within the mammalian epidermal growth factor-related peptide family. J Biol Chem 269: 22817-22822, 1994.
5. Bjerknes M, Cheng H. Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci U S A 98: 12497-12502, 2001.
6. Dahly EM, Gillingham MB, Guo Z, Murali SG, Nelson DW, Holst JJ, Ney DM. Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection. Am J Physiol Gastrointest Liver Physiol 284: G670-G682, 2003.
7. Damstrup L, Kuwada SK, Dempsey PJ, Brown CL, Hawkey CJ, Poulsen HS, Wiley HS, Coffey RJ Jr. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Br J Cancer 80: 1012-1019, 1999.
8. Deniz M, Kilinc M, Hatipoglu ES. Morphological alterations in small intestine of rats with myenteric plexus denervation. Eur Surg Res 36: 152-158, 2004.
9. Drozdowski L, Thomson AB. Intestinal hormones and growth factors: effects on the small intestine. World J Gastroenterol 15: 385-406, 2009.
10. Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 93: 7911-7916, 1996.
11. Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, Lin S, Portnoy ME, Cutler DJ, Green ED, Chakravarti A. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 434: 857-863, 2005.
12. Enomoto H, Crawford PA, Gorodinsky A, Heuckeroth RO, Johnson EM Jr, Milbrandt J. RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. Development 128: 3963-3974, 2001.
13. Enomoto H, Heuckeroth RO, Golden JP, Johnson EM Jr, Milbrandt J. Development of cranial parasympathetic ganglia requires sequential actions of GDNF and neurturin. Development 127: 4877-4889, 2000.
14. Garcia SB, Kawasaky MC, Silva JC, Garcia-Rodrigues AC, Borelli-Bovo TJ, Iglesias AC, Zucoloto S. Intrinsic myenteric denervation: a new model to increase the intestinal absorptive surface in short-bowel syndrome. J Surg Res 85: 200-203, 1999.
15. Gianino S, Grider JR, Cresswell J, Enomoto H, Heuckeroth RO. GDNF availability determines enteric neuron number by controlling precursor proliferation. Development 130: 2187-2198, 2003.
16. Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell D, Nichols BL, Burrin DG. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130: 150-164, 2006.
17. Helmrath MA, Erwin CR, Warner BW. A defective EGF-receptor in waved-2 mice attenuates intestinal adaptation. J Surg Res 69: 76-80, 1997.
18. Helmrath MA, Shin CE, Erwin CR, Warner BW. The EGF\EGFreceptor axis modulates enterocyte apoptosis during intestinal adaptation. J Surg Res 77: 17-22, 1998.
19. Helmrath MA, Shin CE, Fox JW, Erwin CR, Warner BW. Adaptation after small bowel resection is attenuated by sialoadenectomy: the role for endogenous epidermal growth factor. Surgery 124: 848-854, 1998.
20. Helmrath MA, VanderKolk WE, Can G, Erwin CR, Warner BW. Intestinal adaptation following massive small bowel resection in the mouse. J Am Coll Surg 183: 441-449, 1996.
21. Kaji T, Tanaka H, Redstone H, Wallace LE, Holst JJ, Sigalet DL. Temporal changes in the intestinal growth promoting effects of glucagonlike peptide 2 following intestinal resection. J Surg Res 152: 271-280, 2009.
22. Knott AW, Juno RJ, Jarboe MD, Profitt SA, Erwin CR, Smith EP, Fagin JA, Warner BW. Smooth muscle overexpression of IGF-I induces a novel adaptive response to small bowel resection. Am J Physiol Gastrointest Liver Physiol 287: G562-G570, 2004.
23. Knott AW, Juno RJ, Jarboe MD, Zhang Y, Profitt SA, Thoerner JC, Erwin CR, Warner BW. EGF receptor signaling affects bcl-2 family gene expression and apoptosis after massive small bowel resection. J Pediatr Surg 38: 875-880, 2003.
24. Kumagai K, Horikawa T, Gotoh A, Yamane S, Yamada H, Kobayashi H, Hamada Y, Suzuki S, Suzuki R. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110: 748-754, 2010.
25. Ljungmann K, Hartmann B, Kissmeyer-Nielsen P, Flyvbjerg A, Holst JJ, Laurberg S. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am J Physiol Gastrointest Liver Physiol 281: G779-G785, 2001.
26. Longshore SW, Nair R, Perrone EE, Erwin CR, Guo J, Warner BW. p21(waf1/cip1) deficiency does not perturb the intestinal crypt stem cell population after massive small bowel resection. J Pediatr Surg 44: 1065-1071; discussion 1071, 2009.
27. Martin CA, Bernabe KQ, Taylor JA, Nair R, Paul RJ, Guo J, Erwin CR, Warner BW. Resection-induced intestinal adaptation and the role of enteric smooth muscle. J Pediatr Surg 43: 1011-1017, 2008.
28. Martin CA, Perrone EE, Longshore SW, Toste P, Bitter K, Nair R, Guo J, Erwin CR, Warner BW. Intestinal resection induces angiogenesis within adapting intestinal villi. J Pediatr Surg 44: 1077-1082; discussion 1083, 2009.
29. Martin GR, Beck PL, Sigalet DL. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World J Gastroenterol 12: 4117-4129, 2006.
30. Martin GR, Wallace LE, Hartmann B, Holst JJ, Demchyshyn L, Toney K, Sigalet DL. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 288: G431-G438, 2005.
31. McCallion AS, Stames E, Conlon RA, Chakravarti A. Phenotype variation in two-locus mouse models of Hirschsprung disease: tissuespecific interaction between Ret and Ednrb. Proc Natl Acad Sci U S A 100: 1826-1831, 2003.
32. McMellen ME, Wakeman D, Erwin CR, Guo J, Warner BW. Epidermal growth factor receptor signaling modulates chemokine (CXC) ligand 5 expression and is associated with villus angiogenesis after small bowel resection. Surgery 148: 364-370, 2010.
33. McMellen ME, Wakeman D, Longshore SW, McDuffie LA, Warner BW. Growth factors: possible roles for clinical management of the short bowel syndrome. Semin Pediatr Surg 19: 35-43, 2010.
34. Orskov C, Holst JJ, Knuhtsen S, Baldissera FG, Poulsen SS, Nielsen OV. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 119: 1467-1475, 1986.
35. Parvadia JK, Keswani SG, Vaikunth S, Maldonado AR, Marwan A, Stehr W, Erwin C, Uzvolgyi E, Warner BW, Yamano S, Taichman N, Crombleholme TM. Role of VEGF in small bowel adaptation after resection: the adaptive response is angiogenesis dependent. Am J Physiol Gastrointest Liver Physiol 293: G591-G598, 2007.
36. Phay JE, Shah MH. Targeting RET receptor tyrosine kinase activation in cancer. Clin Cancer Res 16: 5936-5941, 2010.
37. Schuchardt A, D'Agati V, Larsson-Blomberg L, Constantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367: 380-383, 1994.
38. Sheng G, Bernabe KQ, Guo J, Warner BW. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression. Gastroenterology 131: 153-164, 2006.
39. Sinclair EM, Yusta B, Streutker C, Baggio LL, Koehler J, Charron MJ, Drucker DJ. Glucagon receptor signaling is essential for control of murine hepatocyte survival. Gastroenterology 135: 2096-2106, 2008.
40. Taylor JA, Bernabe KQ, Guo J, Warner BW. Epidermal growth factor receptor-directed enterocyte proliferation does not induce Wnt pathway transcription. J Pediatr Surg 42: 981-986, 2007.
41. Taylor JA, Martin CA, Nair R, Guo J, Erwin CR, Warner BW. Lessons learned: optimization of a murine small bowel resection model. J Pediatr Surg 43: 1018-1024, 2008.
42. Toumi F, Neunlist M, Cassagnau E, Parois S, Laboisse CL, Galmiche JP, Jarry A. Human submucosal neurones regulate intestinal epithelial cell proliferation: evidence from a novel co-culture model. Neurogastroenterol Motil 15: 239-242, 2003.
43. Vohra BP, Tsuji K, Nagashimada M, Uesaka T, Wind D, Fu M, Armon J, Enomoto H, Heuckeroth RO. Differential gene expression and functional analysis implicate novel mechanisms in enteric nervous system precursor migration and neuritogenesis. Dev Biol 298: 259-271, 2006.
44. Warner BW, Erwin CR. Critical roles for EGF receptor signaling during resection-induced intestinal adaptation. J Pediatr Gastroenterol Nutr 43, Suppl 1: S68-S73, 2006.
45. Warner BW, Vander Kolk WE, Can G, Helmrath MA, Shin CE, Erwin CR. Epidermal growth factor receptor expression following small bowel resection. J Surg Res 70: 171-177, 1997.
46. Yusta B, Holland D, Koehler JA, Maziarz M, Estall JL, Higgins R, Drucker DJ. ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut. Gastroenterology 137: 986-996, 2009.